Rewriting the Real-World Evidence Playbook in Asia Pacific
The complexity of Asia Pacific (APAC) is often viewed as a constraint for real‑world evidence (RWE), with traditional approaches falling short. A change in direction is needed to fully realise RWE potential across this diverse region. Ipsos’ new point of view rewrites the playbook for RWE in APAC, unveiling a tailored and harmonised approach to tackling the region’s inherent heterogeneity. Discover how life sciences companies can navigate the intricacies of regional silos, fragmented data, and a diverse regulatory landscape by leveraging Ipsos’ direct-to-responder approach. The author: Louise Hogg, APAC, Healthcare